BPOC, a pure-play healthcare investor with over 25 years of experience in middle market private equity, has announced the launch of Atlas Clinical Research (“Atlas”), a therapeutically-driven clinical site network built on centralized process excellence and integrated technology, led by experienced pharmaceutical executive, Mark Scullion as Chief Executive Officer. As part of the launch, Atlas has formed a strategic partnership with Rochester Clinical Research (“RCR”), an experienced research site having conducted over 1,000 clinical trials involving 55,000 study volunteers. BPOC, Mr. Scullion, and the team at RCR formed Atlas to build a high-performing clinical research site network through acquisition and organic growth leveraging a centralized platform that will solve critical pain points for pharmaceutical sponsors.
Read the full article: BPOC Launches Atlas Clinical Research, a Premier Clinical Research Site Platform //
Source: https://www.prnewswire.com/news-releases/bpoc-launches-atlas-clinical-research-a-premier-clinical-research-site-platform-301795128.html